Cellect Biotechnology Ltd. (APOP) |
| 13.17 0.05 (0.38%) 10-29 00:00 |
| Open: | 13.12 |
| High: | 13.3188 |
| Low: | 13.1 |
| Volume: | 17,433 |
| Market Cap: | 129(M) |
| PE Ratio: | -15.42 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 29.8 |
| 52w Low: | 1.75 |
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Mon, 21 Jun 2021
Stocks to Buy: Shares That May See a Big Short Squeeze This Week: Fintel - Business Insider
Mon, 01 Feb 2021
Kadimastem hopes to turn corner with new management - Globes - Israel Business News
Tue, 01 Dec 2020
Cellect Biotechnology Stock Price Forecast. Should You Buy APOP? - StockInvest.us
Thu, 05 Mar 2020
Canndoc and Super-Pharm Sign Long-Term Partnership Agreement - PR Newswire
Thu, 14 Sep 2017
Vanda Pharmaceuticals Inc. | $VNDA Stock | Shares Slip After Results from Phase 2 Study of Tradipant - warriortradingnews.com
Fri, 31 Mar 2017
Company Spotlight: Cellect Biotechnology - RTTNews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
